Baird Financial Group
PRAH

Baird Financial Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Baird Financial Group’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,404
Closed -$397K – 1951
2021
Q2 		$397K Sell
2,404
-11,825
-83% -$1.97M ﹤0.01% 1484
2021
Q1 		$2.18M Sell
14,229
-343
-2% -$46.6K 0.01% 852
2020
Q4 		$1.83M Sell
14,572
-95
-0.6% -$10.6K 0.01% 836
2020
Q3 		$1.49M Sell
14,667
-456
-3% -$46.5K 0.01% 829
2020
Q2 		$1.47M Sell
15,123
-12
-0.1% -$1.12K 0.01% 821
2020
Q1 		$1.26M Sell
15,135
-5,675
-27% -$553K 0.01% 825
2019
Q4 		$2.31M Buy
20,810
+15,538
+295% +$1.6M 0.01% 726
2019
Q3 		$523K Buy
5,272
+281
+6% +$27.9K ﹤0.01% 1157
2019
Q2 		$495K Buy
+4,991
New +$476K ﹤0.01% 1199

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Baird Financial Group's PRAH Position: Q3 2021 in Review

Baird Financial Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,404 shares — an estimated $397K sold.

Baird Financial Group first reported a position in PRAH in Q2 2019 and held it in 9 quarters. The position peaked at $2.31M in Q4 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Baird Financial Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Baird Financial Group sold 2,404 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $397K.
  • Baird Financial Group first reported a position in PRA Health Sciences, Inc. in Q2 2019 and held it in 9 quarters.
  • Baird Financial Group's PRA Health Sciences, Inc. position peaked at $2.31M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Baird Financial Group's 13F filing for Q3 2021, filed 12 Nov 2021.